Purulent Urethritis (Empiric Treatment)
Empiric treatment is recommended for purulent urethral discharge when gonorrhea is likely or diagnostic testing is unavailable or results are unlikely to return promptly. [1] The treatment of choice is intramuscular ceftriaxone plus doxycycline when concurrent chlamydial infection has not been excluded. [1], [2]
Medication Selection Algorithm
Empiric therapy for purulent urethritis should cover likely gonorrhea and chlamydia. [1]
- Cephalosporin for gonorrhea (ceftriaxone) (examples: ceftriaxone 500 mg IM once). [1], [2]
- Doxycycline for possible chlamydia (examples: doxycycline 100 mg orally twice daily for 7 days). [1], [2]
Key Evidence Supporting This Recommendation
CDC recommends single-agent ceftriaxone therapy for uncomplicated gonorrhea, with doxycycline added when chlamydial infection has not been excluded. [2]
Monotherapy vs Combination Therapy
Monotherapy with ceftriaxone is recommended for uncomplicated gonorrhea only when chlamydia has been excluded. [2] Combination therapy with ceftriaxone plus doxycycline is recommended when chlamydial infection has not been excluded. [2]
Important Clarifications or Nuances
Purulent urethritis does not change empiric antimicrobial selection in older adults. [1] Nucleic acid amplification testing for gonorrhea and chlamydia should be performed when possible to allow regimen targeting. [1]
Initiation Thresholds or Indications
Empiric treatment is recommended when urethritis is suspected based on clinical presentation and the patient is at high risk or is unlikely to return for follow-up or test results. [1]
Common Pitfalls to Avoid
Cefixime is not recommended as the primary regimen for uncomplicated urogenital gonorrhea due to lower sustained bactericidal exposure compared with ceftriaxone. [2] Omission of doxycycline is a pitfall when chlamydial coinfection has not been excluded. [2]
Target Blood Pressure
Not applicable to purulent urethritis management.